Menting JG, Whittaker J, Margetts MB, Whittaker LJ, Kong GK, Smith BJ, Watson CJ, Záková L, Kletvíková E, Jiráček J, Chan SJ, Steiner DF, Dodson GG, Brzozowski AM, Weiss MA, Ward CW, Lawrence MC. How insulin engages its primary binding site on the insulin receptor. Nature. 2013;493:241–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ogawa W, Araki E, Ishigaki Y, Hirota Y, Maegawa H, Yamauchi T, Yorifuji T, Katagiri H. New classification and diagnostic criteria for insulin resistance syndrome. Diabetol Int. 2022;13:337–43.

Article  PubMed  PubMed Central  Google Scholar 

Longo N, Wang Y, Smith SA, Langley SD, DiMeglio LA, Giannella-Neto D. Genotype-phenotype correlation in inherited severe insulin resistance. Hum Mol Genet. 2002;11:1465–75.

Article  CAS  PubMed  Google Scholar 

Iqbal J, Jiang HL, Wu HX, Li L, Zhou YH, Hu N, Xiao F, Wang T, Xu SN, Zhou HD. Hereditary severe insulin resistance syndrome: pathogenesis, pathophysiology, and clinical management. Genes Dis. 2022;10:1846–56.

Article  PubMed  PubMed Central  Google Scholar 

Plamper M, Gohlke B, Schreiner F, Woelfle J. Mecasermin in insulin receptor-related severe insulin resistance syndromes: case report and review of the literature. Int J Mol Sci. 2018;19:1268.

Article  PubMed  PubMed Central  Google Scholar 

Yamoto K, Saitsu H, Nakagawa N, Nakajima H, Hasegawa T, Fujisawa Y, Kagami M, Fukami M, Ogata T. De novo IGF2 mutation on the paternal allele in a patient with Silver-Russell syndrome and ectrodactyly. Hum Mutat. 2017;38:953–8.

Article  CAS  PubMed  Google Scholar 

Kushi R, Hirota Y, Ogawa W. Insulin resistance and exaggerated insulin sensitivity triggered by single-gene mutations in the insulin signaling pathway. Diabetol Int. 2020;12:62–7.

Article  PubMed  PubMed Central  Google Scholar 

Livingstone C, Collison M. Sex steroids and insulin resistance. Clin Sci. 2002;102:151–66.

Article  CAS  Google Scholar 

Hovnik T, Bratanič N, Podkrajšek KT, Kovač J, Paro D, Podnar T, Bratina N, Battelino T. Severe progressive obstructive cardiomyopathy and renal tubular dysfunction in Donohue syndrome with decreased insulin receptor autophosphorylation due to a novel INSR mutation. Eur J Pediatr. 2013;172:1125–9.

Article  PubMed  Google Scholar 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee, ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17:405–24.

Article  PubMed  PubMed Central  Google Scholar 

Chrzanowska J, Skarul J, Zubkiewicz-Kucharska A, Borowiec M, Zmyslowska A. Incomplete phenotypic presentation in a girl with rare Rabson-Mendenhall syndrome. Acta Diabetol. 2023;60:449–53.

Article  PubMed  Google Scholar 

Kelsey MM, Zeitler PS. Insulin resistance of puberty. Curr Diab Rep. 2016;16:64.

Article  PubMed  Google Scholar 

Masunaga Y, Fujisawa Y, Muramatsu M, Ono H, Inoue T, Fukami M, Kagami M, Saitsu H, Ogata T. Insulin resistant diabetes mellitus in SHORT syndrome: case report and literature review. Endocr J. 2021;68:111–7.

Article  PubMed  Google Scholar 

Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes. 2019;12:1047–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yorifuji T, Higuchi S, Hosokawa Y, Kawakita R. Chromosome 6q24-related diabetes mellitus. Clin Pediatr Endocrinol. 2018;27:59–65.

Article  PubMed  PubMed Central  Google Scholar 

Nagashima S, Wakabayashi T, Saito N, Takahashi M, Okada K, Ebihara K, Ishibashi S. Long-term efficacy of the sodium-glucose cotransporter 2 inhibitor, ipragliflozin, in a case of type A insulin resistance syndrome. J Diabetes Investig. 2020;11:1363–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dos Santos SS, Ramaldes LA, Gabbay MAL, Moises RCS, Dib SA. Use of a sodium-glucose cotransporter 2 inhibitor, empagliflozin, in a patient with Rabson-Mendenhall Syndrome. Horm Res Paediatr. 2021;94:313–6.

Article  PubMed  Google Scholar